Quest Diagnostics SVP Acquires Shares via DRIP Plan
QUEST DIAGNOSTICS INC
Subscribe to track DGX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Quest Diagnostics SVP Acquires Shares via DRIP Plan
Company: QUEST DIAGNOSTICS INC (DGX) Form: 4 | Filed: 2025-10-24 Significance: Low
Insider: KUPPUSAMY KARTHIK Title: SVP, Clinical Solutions | Relationship: Officer
Transaction: • Type: Acquisition (DRIP) • Shares: 15 • Price: $189.08 • Value: $2,836 • Owned After: 10,372 (Total Direct & Indirect)
Key Insight: This is a minor, routine acquisition of 15 shares through a dividend reinvestment plan (DRIP), as noted in the filing. It does not represent a significant insider sentiment shift.
Market Context: The transaction value is negligible (0.000014%) relative to Quest's $20.54B market capitalization.
Comprehensive Analysis
SEC Filing Analysis: QUEST DIAGNOSTICS INC (DGX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer acquired a nominal number of shares through a routine dividend reinvestment plan (DRIP), a transaction with no material significance.
- Market Impact: Neutral. This type of transaction is automated and does not reflect a discretionary investment decision by the insider.
Company Information
| Field | Value |
|---|---|
| Company | QUEST DIAGNOSTICS INC |
| Ticker Symbol | DGX |
| CIK | 0001022079 |
| Industry | Medical Laboratories |
Insider Information
| Field | Value |
|---|---|
| Name | KUPPUSAMY KARTHIK |
| CIK | 0001955217 |
| Title/Position | SVP, Clinical Solutions |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-21 |
| Transaction Code | A (Acquisition) |
| Security Type | Common Stock |
| Shares Involved | 15 |
| Price Per Share | $189.076 |
| Total Value | $2,836.14 |
| Shares Owned After | 8,379 (Directly) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $2,836.14 |
| % of Market Cap | 0.000014% |
| Shares Transacted | 15 |
| % of Shares Outstanding | 0.000013% |
| Post-Transaction Ownership | 10,372 shares (0.0093% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a company with a $20.54 billion market cap, a transaction valued at approximately $2,800 is financially immaterial.
- Ownership Concentration: The insider's total holdings of 10,372 shares represent a very small fraction (0.0093%) of the total shares outstanding, indicating low ownership concentration.
- Dilution Impact: Not applicable, as this was an open-market acquisition via a DRIP, not an issuance of new shares.
- Transaction Significance: The transaction is insignificant, representing less than 0.0001% of both market cap and shares outstanding. It is a passive investment action, not an active trading decision.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is too small to have any market impact. It is a non-discretionary acquisition resulting from a dividend reinvestment plan, which carries no informational value about the company's future prospects.
Volume & Sentiment
- Expected Volume Impact: None. The trade size is negligible.
- Sentiment Indicator: Neutral. This filing does not provide a bullish or bearish signal.
Investment Insights
Positive Market Indicators
- None. This transaction is a routine, automated event.
Risk Factors
- The primary risk is misinterpreting this routine filing as a meaningful insider purchase.
Key Takeaways
- Routine Transaction: The acquisition was made via a dividend reinvestment plan (DRIP), as disclosed in the filing's footnotes.
- Immaterial Value: The transaction's value of ~$2,836 is negligible compared to the company's $20.54B market cap.
- No Signal: This filing provides no new insight into insider confidence or company performance.
Additional Context
Transaction Notes
- Special Circumstances: Footnote 1 explicitly states the shares were acquired via a dividend reinvestment plan. The insider chose to report this transaction, which is eligible for deferred reporting on Form 5, early on this Form 4.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
